Erratum: Imaging dopamine transmission in the frontal cortex: A simultaneous microdialysis and [11C]FLB 457 PET study (Molecular Psychiatry (2013)) DOI:10.1038/mp.2013.9);Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and 11 CFLB 457 PET study

Molecular Psychiatry

Volumn 19, Issue 3, 2014, Pages 302-310

  Narendran, R ^a,b   Jedema, H P ^b   Lopresti, B J ^a   Mason, N S ^a   Gurnsey, K ^b   Ruszkiewicz, J ^a   Chen, C M ^a   Deuitch, L ^a   Frankle, W G ^a,b   Bradberry, C W ^b,c  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VA Pittsburgh Health Services   (United States)

Author keywords

Microdialysis; Positron emission tomography; 11C FLB 457

Indexed keywords

AMPHETAMINE; FLB 457 C 11; RACLOPRIDE C 11; TRACER; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTRAST SENSITIVITY; CORPUS STRIATUM; DIALYSATE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG BLOOD LEVEL; FRONTAL CORTEX; IMAGE ANALYSIS; MALE; MICRODIALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHESUS MONKEY;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; FRONTAL LOBE; FUNCTIONAL NEUROIMAGING; MACACA MULATTA; MALE; MICRODIALYSIS; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RACLOPRIDE; RADIOLIGAND ASSAY; SALICYLAMIDES; SYNAPTIC TRANSMISSION;

EID: 84894540696     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.52     Document Type: Erratum

References (52)

1. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS et al. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 1997; 25: 1-14
2. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, deBartolomeis A et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94: 2569-2574
3. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, De Souza CD, Erdos J et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235-9240
4. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007; 64: 932-940
5. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al. Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-Administer cocaine. Am J Psychiatry 2007; 164: 622-629
6. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833
7. Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B et al. Amphetamine-induced displacement of [(18)F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 2005; 31: 1016-1026
8. Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A et al. Small effect of dopamine release and no effect of dopamine depletion on [(18)F]fallypride binding in healthy humans. Synapse 2008; 62: 399-408
9. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE et al. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 2009; 63: 447-461
10. Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J et al. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 2010; 64: 350-362
11. Narendran R, Mason NS, May MA, Chen CM, Kendro S, Ridler K et al. PET imaging of dopamine D(2/3) receptors in the human cortex with [(11)C]FLB 457: Reproducibility studies. Synapse 2010; 65: 35-40
12. Narendran R, Mason NS, Chen CM, Himes M, Keating P, May MA et al. Evaluation of dopamine D/specific binding in the cerebellum for the positron emission tomography radiotracer [(1)(1)C]FLB 457: Implications for measuring cortical dopamine release. Synapse 2011; 65: 991-997
13. Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse 1993; 13: 215-222
14. Garris PA, Wightman RM. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J Neurosci 1994; 14: 442-450
15. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 2000; 20: 423-451
16. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn R, Searle GE et al. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 2009; 63: 447-461
17. Narendran R, Mason NS, Laymon C, Lopresti B, Velasquez N, May M et al. A comparative evaluation of the dopamine D2/3 agonist radiotracer [11C]NPA and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J Pharmacol Exp Ther 2010; 63: 574-584
18. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T et al. Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 2001; 22: 1215-1221
19. Bradberry CW, Barrett-Larimore RL, Jatlow P, Rubino SR. Impact of self-Administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys. J Neurosci 2000; 20: 3874-3883
20. Bradberry CW. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 2000; 20: 7109-7115
21. Bradberry CW. Applications of microdialysis methodology in nonhuman primates: Practice and rationale. Crit Rev Neurobiol 2000; 14: 143-163
22. Bradberry CW. Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys: Comparison with cocaine across individuals. Psychopharmacology (Berl) 2002; 165: 67-76
23. Bradberry CW, Rubino SR. Phasic alterations in dopamine and serotonin release in striatum and prefrontal cortex in response to cocaine predictive cues in behaving rhesus macaques. Neuropsychopharmacology 2004; 29: 676-685
24. Nicholson C, Rice ME. The migration of substances in the neuronal microenvironment. Ann N Y Acad Sci 1986; 481: 55-71
25. Glick SD, Dong N, Keller Jr RW, Carlson JN. Estimating extracellular concentrations of dopamine and 3,4-dihydroxyphenylacetic acid in nucleus accumbens and striatum using microdialysis: Relationships between in vitro and in vivo recoveries. J Neurochem 1994; 62: 2017-2021
26. Carson RCM, Vuong B-K, Watabe H, Herscovitch P, Eckelman W. Amphetamine induced dopamine release: Duration of action assessed with [11C]raclopride in anesthetized monkeys. In Gjedde A, Hansen S, Knudsen G, Paulson O (eds) Physiological Imaging of the Brain with PET. Academic Press: San Diego, 2001, pp 205-209
27. Guo N, Guo W, Kralikova M, Jiang M, Schieren I, Narendran R et al. Impact of d2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology 2010; 35: 806-817
28. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A et al. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model. NeuroImage 2010; 50: 1402-1407
29. Narendran R, Slifstein M, Hwang DR, Hwang Y, Scher E, Reeder S et al. Amphetamine- induced dopamine release: Duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primate. Synapse 2007; 61: 106-109
30. Jedema HP, Gianaros PJ, Greer PJ, Kerr DD, Liu S, Higley JD et al. Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. Mol Psychiatry 2010; 15: 512-522, 446
31. Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T et al. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 1995; 36: 1275-1281
32. Halldin C, Farde L, Hogberg T, Hall H, Strom P, Ohlberger A et al. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. Int J Rad Appl Instrum B 1991; 18: 871-881
33. Watson C. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 2000; 47: 1587-1594
34. Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M et al. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: Validation and reproducibility. J Cereb Blood Flow Metab 2000; 20: 225-243
35. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4(Part 1): 153-158
36. Reimer ML, Mamer OA, Zavitsanos AP, Siddiqui AW, Dadgar D. Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 1993; 22: 235-242
37. Narendran R. Validation of [C-11]FLB 457 as a tool to measure cortical dopamine release. Neuropsychopharmacology 2011; 36: 20
38. Abi-Dargham A. Decreased cortical dopamine release in schizophrenia: Evidence from in vivo imaging. Neuropsychopharmacology 2011; 36: 20
39. Seeman P, Guan H-C, Niznik HB. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain. Synapse 1989; 3: 96-97
40. Hartvig P, Torstenson R, Tedroff J, Watanabe Y, Fasth KJ, Bjurling P et al. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. J Neural Transm 1997; 104: 329-339
41. Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R et al. Estimation of baseline dopamine D(2) receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [(18)F] fallypride. Biol Psychiatry 2008; 63: 241-244
42. Frankle WG, Mason NS, Rabiner EA, Ridler K, May MA, Asmonga D et al. No effect of dopamine depletion on the binding of the high affinity D(2/3) radiotracer [(11)C]FLB 457 in the human cortex. Synapse 2010; 64: 879-885
43. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 2010; 67: 231-239
44. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Nat Acad Sci USA 2000; 97: 8104-8109
45. Chou YH, Halldin C, Farde L. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: A PET study. Synapse 2000; 38: 138-143
46. Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K. Effect of endogenous dopamine on endogenous dopamine on extrastriated [(11)C]FLB 457 binding measured by PET. Synapse 2001; 41: 87-95
47. Aalto S, Hirvonen J, Kaasinen V, Hagelberg N, Kajander J, Nagren K et al. The effects of d-Amphetamine on extrastriatal dopamine D(2)/D (3) receptors: A randomized, double-blind, placebo-controlled PET study with [(11)C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging 2008; 36: 475-483
48. Montgomery AJ, Asselin MC, Farde L, Grasby PM. Measurement of methylphenidate- induced change in extrastriatal dopamine concentration using [(11)C]FLB 457 PET. J Cereb Blood Flow Metab 2007; 27: 369-377
49. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL et al. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia. Biol Psychiatry 2000; 48: 627-640
50. Saunders RC, Kolachana BS, Weinberger DR. Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: An in vivo microdialysis study. Exp Brain Res 1994; 98: 44-52
51. Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochem Int 2008; 52: 119-129
52. Pehek EA. Comparison of effects of haloperidol administration on amphetaminestimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J Pharmacol Exp Ther 1999; 289: 14-23.